News

iCapital Network, a global financial technology platform, has raised $50 million in funding.

Verofax Limited, an asset digitization and traceability solutions provider, has secured $1.5 million in pre-Series A funding.

Great Bay Bio, an AI-enabled biotechnology company, has secured funding from FutureX Capital.

GenFleet Therapeutics, a clinical-stage biotechnology company with a focus on therapies in oncology and immunology, has raised $75 million in Series C financing.

Amberstone Biosciences, an emerging biotherapeutics company, has closed $12 million in Series A financing.

For the third year in a row, we reached out to readers and others to find out who are the rising stars of venture capital. It was no small task, but here is a list of 40 professionals under 40 who are destined to shape VC.

Market conditions and employee expectations have led to a decline in reported happiness when it comes to remuneration, according to research from Benchmark Compensation.

It was a busy year of fundraising amid a pandemic, but more than half of our top 10 stories from 2021 were people-centric, including our annual Rising Stars feature and a few people moves were in the mix, too.

As ESG becomes a more popular strategy, venture firms looked for ways to capitalize on it. Here are five stories of how ESG had a starring role in venture in 2021.

The next year will continue to break fundraising records as VC becomes more mainstream, according to Silicon Valley Bank.